These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 34039294)
1. Socio-economic factors do not affect overall survival in soft tissue sarcoma when patients treated at a single high-volume center. Eastman BM; Hippe DS; Wootton LS; Nyflot MJ; Thompson MJ; Pollack SM; Kim E; Spraker MB BMC Cancer; 2021 May; 21(1):620. PubMed ID: 34039294 [TBL] [Abstract][Full Text] [Related]
2. Association Between Treatment at High-Volume Facilities and Improved Overall Survival in Soft Tissue Sarcomas. Venigalla S; Nead KT; Sebro R; Guttmann DM; Sharma S; Simone CB; Levin WP; Wilson RJ; Weber KL; Shabason JE Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):1004-1015. PubMed ID: 29485042 [TBL] [Abstract][Full Text] [Related]
3. Trends in practice patterns and outcomes: A decade of sarcoma care in the United States. Song Y; Ecker BL; Tang R; Maggino L; Roses RE; DeMatteo RP; Fraker DL; Karakousis GC Surg Oncol; 2019 Jun; 29():168-177. PubMed ID: 31196484 [TBL] [Abstract][Full Text] [Related]
4. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas. Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391 [TBL] [Abstract][Full Text] [Related]
6. Time to treatment initiation and survival in adult localized, high-grade soft tissue sarcoma. Featherall J; Curtis GL; Lawrenz JM; Jin Y; George J; Scott J; Shah C; Shepard D; Rubin BP; Nystrom LM; Mesko NW J Surg Oncol; 2019 Dec; 120(7):1241-1251. PubMed ID: 31587292 [TBL] [Abstract][Full Text] [Related]
7. Pathologic necrosis following neoadjuvant radiotherapy or chemoradiotherapy is prognostic of poor survival in soft tissue sarcoma. Gannon NP; Stemm MH; King DM; Bedi M J Cancer Res Clin Oncol; 2019 May; 145(5):1321-1330. PubMed ID: 30847552 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients. Iqbal N; Shukla NK; Deo SV; Agarwala S; Sharma DN; Sharma MC; Bakhshi S Clin Transl Oncol; 2016 Mar; 18(3):310-6. PubMed ID: 26243399 [TBL] [Abstract][Full Text] [Related]
9. Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival. Movva S; von Mehren M; Ross EA; Handorf E J Natl Compr Canc Netw; 2015 Nov; 13(11):1366-74. PubMed ID: 26553766 [TBL] [Abstract][Full Text] [Related]
10. Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers? Lazarides AL; Kerr DL; Nussbaum DP; Kreulen RT; Somarelli JA; Blazer DG; Brigman BE; Eward WC Clin Orthop Relat Res; 2019 Apr; 477(4):718-727. PubMed ID: 30485258 [TBL] [Abstract][Full Text] [Related]
11. Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative. Zaidi MY; Ethun CG; Tran TB; Poultsides G; Grignol VP; Howard JH; Bedi M; Mogal H; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick B; Fields RC; Oskouei S; Reimer N; Monson D; Maithel SK; Cardona K Ann Surg Oncol; 2019 Oct; 26(11):3542-3549. PubMed ID: 31342400 [TBL] [Abstract][Full Text] [Related]
12. Modern Management of High-risk Soft Tissue Sarcoma With Neoadjuvant Chemoradiation: A Single-center Experience. Byun DJ; Katz LM; Xiao J; Rapp TB; Paoluzzi L; Rosen G; Schiff PB Am J Clin Oncol; 2021 Jan; 44(1):24-31. PubMed ID: 33086232 [TBL] [Abstract][Full Text] [Related]
13. High grade soft tissue sarcoma of the flexor fossae. Size rather than compartmental status determine prognosis. Yang RS; Lane JM; Eilber FR; Dorey FJ; al-Shaikh R; Schumacher LY; Rosen G; Forscher CA; Eckardt JJ Cancer; 1995 Oct; 76(8):1398-405. PubMed ID: 8620414 [TBL] [Abstract][Full Text] [Related]
14. Socio-economic factors affect the outcome of soft tissue sarcoma: an analysis of SEER data. Cheung MR; Kang J; Ouyang D; Yeung V Asian Pac J Cancer Prev; 2014; 15(1):25-8. PubMed ID: 24528034 [TBL] [Abstract][Full Text] [Related]
15. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Keung EZ; Chiang YJ; Cormier JN; Torres KE; Hunt KK; Feig BW; Roland CL Cancer; 2018 Dec; 124(23):4495-4503. PubMed ID: 30317543 [TBL] [Abstract][Full Text] [Related]
17. Intraoperative Electron Radiation Therapy Combined with External Beam Radiation Therapy after Gross Total Resection in Extremity Soft Tissue Sarcoma: A European Pooled Analysis. Roeder F; de Paoli A; Saleh-Ebrahimi L; Alldinger I; Bertola G; Boz G; Navarria F; Cuervo M; Uhl M; Alvarez A; Buechler M; Lehner B; Debus J; Calvo FA; Krempien R Ann Surg Oncol; 2018 Dec; 25(13):3833-3842. PubMed ID: 30276647 [TBL] [Abstract][Full Text] [Related]
19. Oncological outcome of primary non-metastatic soft tissue sarcoma treated by neoadjuvant isolated limb perfusion and tumor resection. Jakob J; Tunn PU; Hayes AJ; Pilz LR; Nowak K; Hohenberger P J Surg Oncol; 2014 Jun; 109(8):786-90. PubMed ID: 24619722 [TBL] [Abstract][Full Text] [Related]
20. Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response Score. Schaefer IM; Hornick JL; Barysauskas CM; Raut CP; Patel SA; Royce TJ; Fletcher CDM; Baldini EH Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):375-383. PubMed ID: 28463157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]